Loading...

Fund Overview

Fund Size

Fund Size

₹112 Cr

Expense Ratio

Expense Ratio

0.66%

ISIN

ISIN

INF663L01Z45

Minimum SIP

Minimum SIP

₹1,000

Exit Load

Exit Load

No Charges

Inception Date

Inception Date

06 Dec 2024

About this fund

PGIM India Healthcare Fund Direct Growth is a Sector - Healthcare mutual fund schemes offered by PGIM India Mutual Fund. This fund has been in existence for 8 months and 28 days, having been launched on 06-Dec-24.
As of 02-Sep-25, it has a Net Asset Value (NAV) of ₹9.92, Assets Under Management (AUM) of 112.33 Crores, and an expense ratio of 0.66%.
  • PGIM India Healthcare Fund Direct Growth has given a CAGR return of -0.80% since inception.
  • The fund's asset allocation comprises around 97.78% in equities, 0.00% in debts, and 2.22% in cash & cash equivalents.
  • You can start investing in PGIM India Healthcare Fund Direct Growth with a SIP of ₹1000 or a Lumpsum investment of ₹5000.

Performance against Category Average

In this section, we compare the returns of the scheme with the category average over various periods. Periods for which the fund has outperformed its category average are marked in green, otherwise red.

Since Inception

-0.80%

(Cat Avg.)

Portfolio Summaryas of 31st July 2025

Equity109.83 Cr97.78%
Others2.5 Cr2.22%

Top Holdings

All Holdings

Equity

Debt & Others

NameType sortAmount sortHoldings sort
Sun Pharmaceuticals Industries LtdEquity14.12 Cr12.57%
Divi's Laboratories LtdEquity9.34 Cr8.31%
Max Healthcare Institute Ltd Ordinary SharesEquity8.67 Cr7.72%
Dr Reddy's Laboratories LtdEquity6.97 Cr6.21%
Aster DM Healthcare Ltd Ordinary SharesEquity6.16 Cr5.48%
Mankind Pharma LtdEquity5.76 Cr5.13%
Torrent Pharmaceuticals LtdEquity5.01 Cr4.46%
Krishna Institute of Medical Sciences LtdEquity4.4 Cr3.92%
Abbott India LtdEquity4.09 Cr3.64%
Ajanta Pharma LtdEquity3.92 Cr3.49%
Global Health LtdEquity3.47 Cr3.09%
PB Fintech LtdEquity3.2 Cr2.85%
Cipla LtdEquity3.06 Cr2.73%
Dr. Lal PathLabs LtdEquity2.98 Cr2.65%
Navin Fluorine International LtdEquity2.89 Cr2.58%
ICICI Lombard General Insurance Co LtdEquity2.7 Cr2.40%
Jupiter Life Line Hospitals LtdEquity2.64 Cr2.35%
J.B. Chemicals & Pharmaceuticals LtdEquity2.39 Cr2.13%
Ipca Laboratories LtdEquity2.37 Cr2.11%
Sagility India LtdEquity2.33 Cr2.07%
Rainbow Childrens Medicare LtdEquity2.29 Cr2.04%
Neuland Laboratories LtdEquity2.25 Cr2.00%
Clearing Corporation Of India Ltd.Cash - Repurchase Agreement2.17 Cr1.93%
Syngene International LtdEquity1.86 Cr1.66%
Sanofi India LtdEquity1.69 Cr1.50%
Sai Life Sciences LtdEquity1.53 Cr1.37%
Anthem Biosciences LtdEquity1.21 Cr1.07%
Zydus Lifesciences LtdEquity1.14 Cr1.02%
Orchid Pharma LtdEquity0.87 Cr0.78%
Dr Agarwal'S Eye Hospital LtdEquity0.52 Cr0.46%
Net Receivables / (Payables)Cash0.33 Cr0.30%

Allocation By Market Cap (Equity)

Large Cap Stocks

48.13%

Mid Cap Stocks

17.58%

Small Cap Stocks

30.99%

Other Allocation

Equity Sector

Debt & Others

SectorAmount sortHoldings sort
Healthcare101.04 Cr89.94%
Financial Services5.9 Cr5.26%
Basic Materials2.89 Cr2.58%

Risk & Performance Ratios

Standard Deviation

This fund

--

Cat. avg.

15.89%

Lower the better

Sharpe Ratio

This fund

--

Cat. avg.

0.99

Higher the better

Sortino Ratio

This fund

--

Cat. avg.

1.79

Higher the better

Fund Managers

PP

Puneet Pal

Since January 2025

AP

Anandha Padmanabhan Anjeneyan

Since January 2025

UM

Utsav Mehta

Since January 2025

VS

Vivek Sharma

Since January 2025

Additional Scheme Detailsas of 31st July 2025

ISIN
INF663L01Z45
Expense Ratio
0.66%
Exit Load
No Charges
Fund Size
₹112 Cr
Age
8 months
Lumpsum Minimum
₹5,000
Fund Status
Open Ended Investment Company
Benchmark
BSE Healthcare TR INR

Investment ObjectiveInvestment Objective

To seek to generate long-term capital growth from an actively managed portfolio primarily of Equity and Equity Related Securities. Scheme shall invest in Indian equities,foreign equities and related instruments and debt securities.

Tax Treatment

iconCapital Gains Taxation:

iconDividend Taxation:

info icon

Note: As per the Income Tax Budget 2024, mutual funds are subject to capital gains taxation, which includes surcharge and cess based on prevailing income tax rules and the investor’s income. Taxation applies only to realised gains, not notional gains. Please consult your tax advisors to determine the implications or consequences of your investments in such securities.

Similar Sector - Healthcare Funds

Fund nameExpense RatioExit LoadFund size
1Y
Baroda BNP Paribas Health and Wellness Fund Direct Growth

Very High Risk

0.4%1.0%₹670.42 Cr-
Baroda BNP Paribas Health and Wellness Fund Regular Growth

Very High Risk

2.3%1.0%₹670.42 Cr-
Bajaj Finserv Healthcare Fund Regular Growth

Very High Risk

2.4%1.0%₹341.35 Cr-
Bajaj Finserv Healthcare Fund Direct Growth

Very High Risk

0.7%1.0%₹341.35 Cr-
PGIM India Healthcare Fund Direct Growth

Very High Risk

0.7%0.0%₹112.33 Cr-
PGIM India Healthcare Fund Regular Growth

Very High Risk

2.4%0.0%₹112.33 Cr-
WhiteOak Capital Pharma and Healthcare Fund Regular Growth

Very High Risk

2.4%1.0%₹409.43 Cr9.7%
WhiteOak Capital Pharma and Healthcare Fund Direct Growth

Very High Risk

0.7%1.0%₹409.43 Cr11.6%
DSP Nifty Healthcare ETF Regular Growth

Very High Risk

0.2%-₹10.65 Cr-0.0%
Kotak Healthcare Fund Direct Growth

Very High Risk

0.8%0.0%₹485.27 Cr1.2%
Kotak Healthcare Fund Regular Growth

Very High Risk

2.4%0.0%₹485.27 Cr-0.4%
HDFC Pharma and Healthcare Fund Regular Growth

Very High Risk

2.1%1.0%₹1936.05 Cr8.5%
HDFC Pharma and Healthcare Fund Direct Growth

Very High Risk

0.9%1.0%₹1936.05 Cr9.8%
Nippon India Pharma Fund Direct Growth

Very High Risk

0.9%1.0%₹8736.57 Cr-0.5%
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Regular Growth

Very High Risk

1.9%1.0%₹6103.96 Cr4.2%
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth

Very High Risk

1.0%1.0%₹6103.96 Cr5.0%
DSP Healthcare Fund Direct Growth

Very High Risk

0.6%0.0%₹3190.15 Cr1.4%
DSP Healthcare Fund Regular Growth

Very High Risk

1.9%0.0%₹3190.15 Cr0.0%
LIC MF Healthcare Fund Direct Growth

Very High Risk

1.2%1.0%₹90.98 Cr2.3%
LIC MF Healthcare Fund Regular Growth

Very High Risk

2.5%1.0%₹90.98 Cr1.0%
quant Healthcare Fund Direct Growth

Very High Risk

0.8%1.0%₹409.22 Cr-10.6%
quant Healthcare Fund Regular Growth

Very High Risk

2.4%1.0%₹409.22 Cr-12.1%
UTI Healthcare Fund Direct Growth

Very High Risk

1.3%1.0%₹1146.13 Cr4.1%
SBI Healthcare Opportunities Fund Direct Growth

Very High Risk

0.9%0.0%₹4026.55 Cr6.1%
Tata India Pharma & Healthcare Fund Regular Growth

Very High Risk

2.1%0.0%₹1339.00 Cr-0.8%
Tata India Pharma & Healthcare Fund Direct Growth

Very High Risk

0.6%0.0%₹1339.00 Cr0.7%
ICICI Prudential Nifty Healthcare ETF

Very High Risk

0.1%-₹146.40 Cr0.0%
SBI Healthcare Opportunities Fund Regular Growth

Very High Risk

1.9%0.0%₹4026.55 Cr5.0%
Nippon India Pharma Fund Regular Growth

Very High Risk

1.8%1.0%₹8736.57 Cr-1.4%
UTI Healthcare Fund Regular Growth

Very High Risk

2.3%1.0%₹1146.13 Cr3.1%
Axis NIFTY Healthcare ETF

Very High Risk

0.3%-₹20.49 Cr-0.2%
Nippon India Nifty Pharma ETF

Very High Risk

0.2%-₹942.04 Cr-5.1%
Mirae Asset Healthcare Fund Regular Growth

Very High Risk

1.9%1.0%₹2908.21 Cr-0.9%
Mirae Asset Healthcare Fund Direct Growth

Very High Risk

0.5%1.0%₹2908.21 Cr0.5%
ITI Pharma and Healthcare Fund Regular Growth

Very High Risk

2.4%0.0%₹235.68 Cr-2.2%
ITI Pharma and Healthcare Fund Direct Growth

Very High Risk

0.5%0.0%₹235.68 Cr-0.4%
Aditya Birla Sun Life Nifty Healthcare ETF

Very High Risk

0.2%-₹36.57 Cr-0.1%
Aditya Birla Sun Life Pharma & Healthcare Fund Regular Growth

Very High Risk

2.3%1.0%₹871.69 Cr-2.7%
Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth

Very High Risk

1.0%1.0%₹871.69 Cr-1.4%
Motilal Oswal S&P BSE Healthcare ETF

Very High Risk

0.2%-₹21.23 Cr2.0%

About the AMC

PGIM India Mutual Fund

PGIM India Mutual Fund

Total AUM

₹25,553 Cr

Address

Nirlon House, 2nd Floor, Mumbai, 400 030

Other Funds by PGIM India Mutual Fund

Fund nameExpense RatioExit LoadFund size
1Y
PGIM India Healthcare Fund Direct Growth

Very High Risk

0.7%0.0%₹112.33 Cr-
PGIM India Multi Cap Fund Direct Growth

Very High Risk

0.6%0.0%₹410.94 Cr-
PGIM India Retirement Fund Direct Growth

Very High Risk

0.7%0.0%₹90.78 Cr4.5%
PGIM India Large and Mid Cap Fund Direct Growth

Very High Risk

0.6%0.0%₹730.52 Cr4.2%
PGIM India Fixed Duration Fund - Series BH Direct Growth

Moderate Risk

-0.0%--
PGIM India Fixed Duration Fund - Series BJ Direct Growth

Moderate Risk

-0.0%--
PGIM India Fixed Duration Fund - Series BI Direct Growth

Moderate Risk

-0.0%--
PGIM India Fixed Duration Fund - Series BF Direct Growth

Moderate Risk

-0.0%--
PGIM India Fixed Duration Fund - Series BG Direct Growth

Moderate Risk

-0.0%--
PGIM India Overnight Fund Direct Growth

Low Risk

0.1%0.0%₹83.56 Cr6.2%
PGIM India Dynamic Bond Direct Growth

Moderate Risk

0.4%0.0%₹109.34 Cr6.8%
PGIM India Global Select Real Estate Securities Fund of Fund Direct Growth

Very High Risk

1.3%0.0%₹44.64 Cr6.9%
PGIM India Balanced Advantage Fund Direct Growth

Moderately High risk

0.5%0.0%₹964.70 Cr2.7%
PGIM India CRISIL IBX Gilt Index - Apr 2028 Fund Direct Growth

Low to Moderate Risk

0.3%0.0%₹27.04 Cr8.2%
PGIM India Flexi Cap Fund Direct Growth

Very High Risk

0.4%0.0%₹6271.27 Cr1.6%
PGIM India Gilt Fund Direct Growth

Moderate Risk

0.6%0.0%₹108.93 Cr5.3%
PGIM India Global Equity Opportunities Fund Direct Growth

Very High Risk

1.4%0.0%₹1496.53 Cr8.7%
PGIM India Emerging Markets Equity Fund Direct Growth

Very High Risk

1.4%0.0%₹342.76 Cr22.9%
PGIM India Liquid Fund Direct Growth

Low to Moderate Risk

0.1%0.0%₹544.58 Cr7.0%
PGIM India Low Duration Fund Direct Growth

Low to Moderate Risk

0.4%0.0%₹93.31 Cr7.2%
PGIM India Corporate Bond Fund Direct Growth

Moderate Risk

0.3%0.0%₹88.63 Cr8.5%
PGIM India Hybrid Equity Fund Direct Growth

High Risk

0.8%0.0%₹216.84 Cr4.4%
PGIM India Large Cap Fund Direct Growth

Very High Risk

0.8%0.0%₹604.19 Cr-0.9%
PGIM India Short Duration Fund Direct Growth

Low to Moderate Risk

0.3%0.0%₹27.94 Cr6.7%
PGIM India Ultra Short Duration Fund Direct Growth

Low to Moderate Risk

0.3%0.0%₹202.36 Cr7.6%
PGIM India Equity Savings Fund Direct Growth

Low to Moderate Risk

0.6%0.0%₹73.13 Cr5.6%
PGIM India Arbitrage Fund Direct Growth

Low Risk

0.4%0.0%₹109.71 Cr6.9%
PGIM India Money Market Fund Direct Growth

Low to Moderate Risk

0.2%0.0%₹268.01 Cr7.8%
PGIM India ELSS Tax Saver Fund Direct Growth

Very High Risk

0.7%0.0%₹779.08 Cr1.3%
PGIM India Midcap Opportunities Fund Direct Growth

Very High Risk

0.5%0.0%₹11468.11 Cr2.6%
PGIM India Credit Risk Fund Segregated Plan 1 Direct Growth

Low to Moderate Risk

-0.0%--
PGIM India Banking and PSU Debt fund Direct Growth

Moderate Risk

0.2%0.0%₹45.38 Cr6.8%
PGIM India Small Cap Fund Direct Growth

Very High Risk

0.5%0.0%₹1582.84 Cr2.2%

Risk Level

Your principal amount will be at Very High Risk

Very High Risk

Take control of your wealth

Track and Analyse all your investments with Wealth Monitor

qr

Rated ★ 4.3+ on

playstoreappstore

Still got questions?
We're here to help.

The NAV of PGIM India Healthcare Fund Direct Growth, as of 02-Sep-2025, is ₹9.92.
The fund's allocation of assets is distributed as 97.78% in equities, 0.00% in bonds, and 2.22% in cash and cash equivalents.
The fund managers responsible for PGIM India Healthcare Fund Direct Growth are:-
  1. Puneet Pal
  2. Anandha Padmanabhan Anjeneyan
  3. Utsav Mehta
  4. Vivek Sharma

Fund Overview

Fund Size

Fund Size

₹112 Cr

Expense Ratio

Expense Ratio

0.66%

ISIN

ISIN

INF663L01Z45

Minimum SIP

Minimum SIP

₹1,000

Exit Load

Exit Load

No Charges

Inception Date

Inception Date

06 Dec 2024

Risk Level

Your principal amount will be at Very High Risk

Very High Risk

About this fund

PGIM India Healthcare Fund Direct Growth is a Sector - Healthcare mutual fund schemes offered by PGIM India Mutual Fund. This fund has been in existence for 8 months and 28 days, having been launched on 06-Dec-24.
As of 02-Sep-25, it has a Net Asset Value (NAV) of ₹9.92, Assets Under Management (AUM) of 112.33 Crores, and an expense ratio of 0.66%.
  • PGIM India Healthcare Fund Direct Growth has given a CAGR return of -0.80% since inception.
  • The fund's asset allocation comprises around 97.78% in equities, 0.00% in debts, and 2.22% in cash & cash equivalents.
  • You can start investing in PGIM India Healthcare Fund Direct Growth with a SIP of ₹1000 or a Lumpsum investment of ₹5000.

Performance against Category Average

In this section, we compare the returns of the scheme with the category average over various periods. Periods for which the fund has outperformed its category average are marked in green, otherwise red.

Since Inception

-0.80%

(Cat Avg.)

Portfolio Summaryas of 31st July 2025

Equity109.83 Cr97.78%
Others2.5 Cr2.22%

Top Holdings

All Holdings

Equity

Debt & Others

NameType sortAmount sortHoldings sort
Sun Pharmaceuticals Industries LtdEquity14.12 Cr12.57%
Divi's Laboratories LtdEquity9.34 Cr8.31%
Max Healthcare Institute Ltd Ordinary SharesEquity8.67 Cr7.72%
Dr Reddy's Laboratories LtdEquity6.97 Cr6.21%
Aster DM Healthcare Ltd Ordinary SharesEquity6.16 Cr5.48%
Mankind Pharma LtdEquity5.76 Cr5.13%
Torrent Pharmaceuticals LtdEquity5.01 Cr4.46%
Krishna Institute of Medical Sciences LtdEquity4.4 Cr3.92%
Abbott India LtdEquity4.09 Cr3.64%
Ajanta Pharma LtdEquity3.92 Cr3.49%
Global Health LtdEquity3.47 Cr3.09%
PB Fintech LtdEquity3.2 Cr2.85%
Cipla LtdEquity3.06 Cr2.73%
Dr. Lal PathLabs LtdEquity2.98 Cr2.65%
Navin Fluorine International LtdEquity2.89 Cr2.58%
ICICI Lombard General Insurance Co LtdEquity2.7 Cr2.40%
Jupiter Life Line Hospitals LtdEquity2.64 Cr2.35%
J.B. Chemicals & Pharmaceuticals LtdEquity2.39 Cr2.13%
Ipca Laboratories LtdEquity2.37 Cr2.11%
Sagility India LtdEquity2.33 Cr2.07%
Rainbow Childrens Medicare LtdEquity2.29 Cr2.04%
Neuland Laboratories LtdEquity2.25 Cr2.00%
Clearing Corporation Of India Ltd.Cash - Repurchase Agreement2.17 Cr1.93%
Syngene International LtdEquity1.86 Cr1.66%
Sanofi India LtdEquity1.69 Cr1.50%
Sai Life Sciences LtdEquity1.53 Cr1.37%
Anthem Biosciences LtdEquity1.21 Cr1.07%
Zydus Lifesciences LtdEquity1.14 Cr1.02%
Orchid Pharma LtdEquity0.87 Cr0.78%
Dr Agarwal'S Eye Hospital LtdEquity0.52 Cr0.46%
Net Receivables / (Payables)Cash0.33 Cr0.30%

Allocation By Market Cap (Equity)

Large Cap Stocks

48.13%

Mid Cap Stocks

17.58%

Small Cap Stocks

30.99%

Other Allocation

Equity Sector

Debt & Others

SectorAmount sortHoldings sort
Healthcare101.04 Cr89.94%
Financial Services5.9 Cr5.26%
Basic Materials2.89 Cr2.58%

Risk & Performance Ratios

Standard Deviation

This fund

--

Cat. avg.

15.89%

Lower the better

Sharpe Ratio

This fund

--

Cat. avg.

0.99

Higher the better

Sortino Ratio

This fund

--

Cat. avg.

1.79

Higher the better

Fund Managers

PP

Puneet Pal

Since January 2025

AP

Anandha Padmanabhan Anjeneyan

Since January 2025

UM

Utsav Mehta

Since January 2025

VS

Vivek Sharma

Since January 2025

Additional Scheme Detailsas of 31st July 2025

ISIN
INF663L01Z45
Expense Ratio
0.66%
Exit Load
No Charges
Fund Size
₹112 Cr
Age
8 months
Lumpsum Minimum
₹5,000
Fund Status
Open Ended Investment Company
Benchmark
BSE Healthcare TR INR

Investment ObjectiveInvestment Objective

To seek to generate long-term capital growth from an actively managed portfolio primarily of Equity and Equity Related Securities. Scheme shall invest in Indian equities,foreign equities and related instruments and debt securities.

Tax Treatment

iconCapital Gains Taxation:

iconDividend Taxation:

info icon

Note: As per the Income Tax Budget 2024, mutual funds are subject to capital gains taxation, which includes surcharge and cess based on prevailing income tax rules and the investor’s income. Taxation applies only to realised gains, not notional gains. Please consult your tax advisors to determine the implications or consequences of your investments in such securities.

Similar Sector - Healthcare Funds

Fund nameExpense RatioExit LoadFund size
1Y
Baroda BNP Paribas Health and Wellness Fund Direct Growth

Very High Risk

0.4%1.0%₹670.42 Cr-
Baroda BNP Paribas Health and Wellness Fund Regular Growth

Very High Risk

2.3%1.0%₹670.42 Cr-
Bajaj Finserv Healthcare Fund Regular Growth

Very High Risk

2.4%1.0%₹341.35 Cr-
Bajaj Finserv Healthcare Fund Direct Growth

Very High Risk

0.7%1.0%₹341.35 Cr-
PGIM India Healthcare Fund Direct Growth

Very High Risk

0.7%0.0%₹112.33 Cr-
PGIM India Healthcare Fund Regular Growth

Very High Risk

2.4%0.0%₹112.33 Cr-
WhiteOak Capital Pharma and Healthcare Fund Regular Growth

Very High Risk

2.4%1.0%₹409.43 Cr9.7%
WhiteOak Capital Pharma and Healthcare Fund Direct Growth

Very High Risk

0.7%1.0%₹409.43 Cr11.6%
DSP Nifty Healthcare ETF Regular Growth

Very High Risk

0.2%-₹10.65 Cr-0.0%
Kotak Healthcare Fund Direct Growth

Very High Risk

0.8%0.0%₹485.27 Cr1.2%
Kotak Healthcare Fund Regular Growth

Very High Risk

2.4%0.0%₹485.27 Cr-0.4%
HDFC Pharma and Healthcare Fund Regular Growth

Very High Risk

2.1%1.0%₹1936.05 Cr8.5%
HDFC Pharma and Healthcare Fund Direct Growth

Very High Risk

0.9%1.0%₹1936.05 Cr9.8%
Nippon India Pharma Fund Direct Growth

Very High Risk

0.9%1.0%₹8736.57 Cr-0.5%
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Regular Growth

Very High Risk

1.9%1.0%₹6103.96 Cr4.2%
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth

Very High Risk

1.0%1.0%₹6103.96 Cr5.0%
DSP Healthcare Fund Direct Growth

Very High Risk

0.6%0.0%₹3190.15 Cr1.4%
DSP Healthcare Fund Regular Growth

Very High Risk

1.9%0.0%₹3190.15 Cr0.0%
LIC MF Healthcare Fund Direct Growth

Very High Risk

1.2%1.0%₹90.98 Cr2.3%
LIC MF Healthcare Fund Regular Growth

Very High Risk

2.5%1.0%₹90.98 Cr1.0%
quant Healthcare Fund Direct Growth

Very High Risk

0.8%1.0%₹409.22 Cr-10.6%
quant Healthcare Fund Regular Growth

Very High Risk

2.4%1.0%₹409.22 Cr-12.1%
UTI Healthcare Fund Direct Growth

Very High Risk

1.3%1.0%₹1146.13 Cr4.1%
SBI Healthcare Opportunities Fund Direct Growth

Very High Risk

0.9%0.0%₹4026.55 Cr6.1%
Tata India Pharma & Healthcare Fund Regular Growth

Very High Risk

2.1%0.0%₹1339.00 Cr-0.8%
Tata India Pharma & Healthcare Fund Direct Growth

Very High Risk

0.6%0.0%₹1339.00 Cr0.7%
ICICI Prudential Nifty Healthcare ETF

Very High Risk

0.1%-₹146.40 Cr0.0%
SBI Healthcare Opportunities Fund Regular Growth

Very High Risk

1.9%0.0%₹4026.55 Cr5.0%
Nippon India Pharma Fund Regular Growth

Very High Risk

1.8%1.0%₹8736.57 Cr-1.4%
UTI Healthcare Fund Regular Growth

Very High Risk

2.3%1.0%₹1146.13 Cr3.1%
Axis NIFTY Healthcare ETF

Very High Risk

0.3%-₹20.49 Cr-0.2%
Nippon India Nifty Pharma ETF

Very High Risk

0.2%-₹942.04 Cr-5.1%
Mirae Asset Healthcare Fund Regular Growth

Very High Risk

1.9%1.0%₹2908.21 Cr-0.9%
Mirae Asset Healthcare Fund Direct Growth

Very High Risk

0.5%1.0%₹2908.21 Cr0.5%
ITI Pharma and Healthcare Fund Regular Growth

Very High Risk

2.4%0.0%₹235.68 Cr-2.2%
ITI Pharma and Healthcare Fund Direct Growth

Very High Risk

0.5%0.0%₹235.68 Cr-0.4%
Aditya Birla Sun Life Nifty Healthcare ETF

Very High Risk

0.2%-₹36.57 Cr-0.1%
Aditya Birla Sun Life Pharma & Healthcare Fund Regular Growth

Very High Risk

2.3%1.0%₹871.69 Cr-2.7%
Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth

Very High Risk

1.0%1.0%₹871.69 Cr-1.4%
Motilal Oswal S&P BSE Healthcare ETF

Very High Risk

0.2%-₹21.23 Cr2.0%

About the AMC

PGIM India Mutual Fund

PGIM India Mutual Fund

Total AUM

₹25,553 Cr

Address

Nirlon House, 2nd Floor, Mumbai, 400 030

Other Funds by PGIM India Mutual Fund

Fund nameExpense RatioExit LoadFund size
1Y
PGIM India Healthcare Fund Direct Growth

Very High Risk

0.7%0.0%₹112.33 Cr-
PGIM India Multi Cap Fund Direct Growth

Very High Risk

0.6%0.0%₹410.94 Cr-
PGIM India Retirement Fund Direct Growth

Very High Risk

0.7%0.0%₹90.78 Cr4.5%
PGIM India Large and Mid Cap Fund Direct Growth

Very High Risk

0.6%0.0%₹730.52 Cr4.2%
PGIM India Fixed Duration Fund - Series BH Direct Growth

Moderate Risk

-0.0%--
PGIM India Fixed Duration Fund - Series BJ Direct Growth

Moderate Risk

-0.0%--
PGIM India Fixed Duration Fund - Series BI Direct Growth

Moderate Risk

-0.0%--
PGIM India Fixed Duration Fund - Series BF Direct Growth

Moderate Risk

-0.0%--
PGIM India Fixed Duration Fund - Series BG Direct Growth

Moderate Risk

-0.0%--
PGIM India Overnight Fund Direct Growth

Low Risk

0.1%0.0%₹83.56 Cr6.2%
PGIM India Dynamic Bond Direct Growth

Moderate Risk

0.4%0.0%₹109.34 Cr6.8%
PGIM India Global Select Real Estate Securities Fund of Fund Direct Growth

Very High Risk

1.3%0.0%₹44.64 Cr6.9%
PGIM India Balanced Advantage Fund Direct Growth

Moderately High risk

0.5%0.0%₹964.70 Cr2.7%
PGIM India CRISIL IBX Gilt Index - Apr 2028 Fund Direct Growth

Low to Moderate Risk

0.3%0.0%₹27.04 Cr8.2%
PGIM India Flexi Cap Fund Direct Growth

Very High Risk

0.4%0.0%₹6271.27 Cr1.6%
PGIM India Gilt Fund Direct Growth

Moderate Risk

0.6%0.0%₹108.93 Cr5.3%
PGIM India Global Equity Opportunities Fund Direct Growth

Very High Risk

1.4%0.0%₹1496.53 Cr8.7%
PGIM India Emerging Markets Equity Fund Direct Growth

Very High Risk

1.4%0.0%₹342.76 Cr22.9%
PGIM India Liquid Fund Direct Growth

Low to Moderate Risk

0.1%0.0%₹544.58 Cr7.0%
PGIM India Low Duration Fund Direct Growth

Low to Moderate Risk

0.4%0.0%₹93.31 Cr7.2%
PGIM India Corporate Bond Fund Direct Growth

Moderate Risk

0.3%0.0%₹88.63 Cr8.5%
PGIM India Hybrid Equity Fund Direct Growth

High Risk

0.8%0.0%₹216.84 Cr4.4%
PGIM India Large Cap Fund Direct Growth

Very High Risk

0.8%0.0%₹604.19 Cr-0.9%
PGIM India Short Duration Fund Direct Growth

Low to Moderate Risk

0.3%0.0%₹27.94 Cr6.7%
PGIM India Ultra Short Duration Fund Direct Growth

Low to Moderate Risk

0.3%0.0%₹202.36 Cr7.6%
PGIM India Equity Savings Fund Direct Growth

Low to Moderate Risk

0.6%0.0%₹73.13 Cr5.6%
PGIM India Arbitrage Fund Direct Growth

Low Risk

0.4%0.0%₹109.71 Cr6.9%
PGIM India Money Market Fund Direct Growth

Low to Moderate Risk

0.2%0.0%₹268.01 Cr7.8%
PGIM India ELSS Tax Saver Fund Direct Growth

Very High Risk

0.7%0.0%₹779.08 Cr1.3%
PGIM India Midcap Opportunities Fund Direct Growth

Very High Risk

0.5%0.0%₹11468.11 Cr2.6%
PGIM India Credit Risk Fund Segregated Plan 1 Direct Growth

Low to Moderate Risk

-0.0%--
PGIM India Banking and PSU Debt fund Direct Growth

Moderate Risk

0.2%0.0%₹45.38 Cr6.8%
PGIM India Small Cap Fund Direct Growth

Very High Risk

0.5%0.0%₹1582.84 Cr2.2%

Still got questions?
We're here to help.

The NAV of PGIM India Healthcare Fund Direct Growth, as of 02-Sep-2025, is ₹9.92.
The fund's allocation of assets is distributed as 97.78% in equities, 0.00% in bonds, and 2.22% in cash and cash equivalents.
The fund managers responsible for PGIM India Healthcare Fund Direct Growth are:-
  1. Puneet Pal
  2. Anandha Padmanabhan Anjeneyan
  3. Utsav Mehta
  4. Vivek Sharma
close

Get your portfolio reviewed by experts

qr

Track all your investments in one place

Download Wealth Monitor App

cross
wm logo

Track and monitor all
your investments